Bromide

Bromide

SCHEMBL1411020

Br.CCOc1cc2c(cc1OC)C(c1cnc(OC)c(OC)c1)=N[C@@H]1CC[C@@H](O)C[C@H]21

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 3/20 0.45
PDE4A P27815 2/20 0.45
PDE4B Q07343 1/20 0.45
PDE4C Q08493 1/20 0.45
FPR2 P25090 15/20 0.38
MEN1 O00255 1/20 0.33
CHRM1 P11229 1/20 0.33
KMT2A Q03164 1/20 0.33
PDE3A Q14432 1/20 0.33
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1411242 0.99 PDE4D (0.46) PDE4DPDE4APDE4BPDE4CFPR2
Hydrochloric Acid SCHEMBL1411429 0.98 PDE4D (0.45) PDE4DPDE4APDE4BPDE4CFPR2
SCHEMBL2263020 0.97 PDE4D (0.46) PDE4DPDE4APDE4BPDE4CFPR2
Oxalic Acid SCHEMBL1410861 0.95 PDE4D (0.46) PDE4DPDE4APDE4BPDE4CFPR2
Sulfuric Acid SCHEMBL1410985 0.95 PDE4D (0.46) PDE4DPDE4APDE4BPDE4CFPR2
Fumaric Acid SCHEMBL1411082 0.92 PDE4D (0.45) PDE4DPDE4APDE4BPDE4CFPR2
Fumaric Acid SCHEMBL1411086 0.92 PDE4D (0.45) PDE4DPDE4APDE4BPDE4CFPR2
Cadaverine Tartrate SCHEMBL1411536 0.92 PDE4D (0.46) PDE4DPDE4APDE4BPDE4CFPR2
Cadaverine Tartrate SCHEMBL1411538 0.92 PDE4D (0.46) PDE4DPDE4APDE4BPDE4CFPR2
Alpha-Ketoglutaric Acid SCHEMBL1411179 0.90 PDE4D (0.43) PDE4DPDE4APDE4BPDE4CFPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194587-A1 phosphodiesterase inhibitor; drug for respiratory system disorders NYCOMED GMBH (DE) 2008-08-14 US claimed
US-8829189-B2 Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives TAKEDA GMBH (DE) 2014-09-09 US disclosed
US-8754218-B2 Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives TAKEDA GMBH (DE) 2014-06-17 US disclosed
US-20140039001-A1 NOVEL SALTS OF 6-HETEROCYCLE SUBSTITUTED HEXAHYDROPHENANTHRIDINE DERIVATIVES TAKEDA GMBH (DE) 2014-02-06 US disclosed
EP-2295423-B1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives TAKEDA GMBH (DE) 2013-10-02 EP disclosed
EP-2189454-B1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives TAKEDA GMBH (DE) 2013-09-25 EP disclosed
US-20130096152-A1 NOVEL SALTS OF 6-HETEROCYCLE SUBSTITUTED HEXAHYDROPHENANTHRIDINE DERIVATIVES NYCOMED GMBH (DE) 2013-04-18 US disclosed
US-8354535-B2 Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives NYCOMED GMBH (DE) 2013-01-15 US disclosed
EP-2295423-A1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives Nycomed GmbH (DE) 2011-03-16 EP disclosed
US-20100190818-A1 Novel salts of 6-heterocycle substituted hexahydrophenanthridine derivatives NYCOMED GMBH (DE) 2010-07-29 US disclosed
EP-2189454-A1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives Nycomed GmbH (DE) 2010-05-26 EP disclosed
US-20080194587-A1 phosphodiesterase inhibitor; drug for respiratory system disorders NYCOMED GMBH (DE) 2008-08-14 US disclosed